Update under Regulation 30 read with clause 20 of Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has filed a routine compliance update with the stock exchange under Regulation 30 of the SEBI Listing Regulations, along with Clause 20 of Para A, Part A of Schedule III. The specific subject matter of the disclosure is not provided in the available headline, but this filing format is commonly used for material corporate events such as changes in directors, auditors, or other key managerial matters. Without the full body of the announcement, key numbers or detailed context cannot be summarized.
This is a procedural regulatory filing, so it is unlikely to have an immediate impact on the stock price. Shareholders should review the full announcement on the exchange website for the specific event disclosed under Clause 20.